Troponin- I Elevation Predicts Outcome After Thrombolysis in Stroke Patients

Cerebrovascular Accident Clinical Trial

Official title: Troponin- I Elevation Predicts Outcome After Thrombolysis in Stroke Patients

Status Completed

Clinical Trial Summary

Elevated level of serum troponin (T-I) has been regarded as a prognostic biomarker of poor outcome in acute ischemic stroke. However, its role in outcome in thrombolysed ischemic stroke patients remains uncertain. The aim of this study was to evaluate the role of T-I as a predictive biomarker of short-term outcome in thrombolysed ischemic stroke participants.

Clinical Trial Description

Elevated level of serum troponin (T-I) has been regarded as a prognostic biomarker of poor outcome in acute ischemic stroke. However, its role in outcome in thrombolysed ischemic stroke patients remains uncertain. The aim of this study was to evaluate the role of T-I as a predictive biomarker of short-term outcome in thrombolysed ischemic stroke patients. Methods: This study included 72 acute ischemic stroke participants were treated with intravenous thrombolytic therapy. All participants were subjected to general and neurological evaluation including assessment of stroke severity using National Institute of Health Stroke Scale (NIHSS) at admission and investigations including measurement of serum level of T-I on admission. Outcome was assessed three months after stroke onset using NIHSS and modified Rankin scale (mRS). ;

Related Conditions & MeSH terms

• Cerebrovascular Accident
• Stroke

• NCT number: NCT03925298
• Study type: Observational [Patient Registry]
• Source: Zagazig University
• Status: Completed
• Start date: January 1, 2017
• Completion date: March 31, 2019